NUS$8.61
$8.60
Chart
Performance
Key Stats
AI NUS Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
NeutralNu Skin Enterprises presents a mixed investment profile. While its valuation appears attractive and it offers a substantial dividend yield, recent performance, profitability trends, and technical indicators suggest caution. The company operates in the beauty and wellness sector, which can be sensitive to consumer spending and competition.
Thematic
Nu Skin operates in the beauty and wellness sector, which has moderate growth potential. Key themes include direct selling, health supplements, and anti-aging products. The company's ability to adapt to evolving consumer preferences and leverage digital platforms will be crucial for future growth.
Fundamental
Nu Skin's fundamental profile shows a mixed picture. While the valuation appears attractive with a low P/E ratio (TTM) and a significant dividend yield, recent performance indicates declining revenue and net income. The company's balance sheet is moderately leveraged, and free cash flow generation has been variable.
Technical
The stock's technical indicators suggest a bearish short-term outlook. The price is trading below key moving averages, and momentum indicators are generally weak. Support levels are being tested, and a breakdown could lead to further declines.
| Factor | Score |
|---|---|
| Beauty & Wellness Market Trends | 65 |
| Direct Selling / Multi-Level Marketing (MLM) | 50 |
| E-commerce & Digital Transformation | 60 |
| Competition | 40 |
| Regulatory Environment (MLM) | 40 |
| Factor | Score |
|---|---|
| Valuation | 80 |
| Profitability | 20 |
| Growth | 15 |
| Balance Sheet Health | 60 |
| Cash Flow | 50 |
| Dividend Yield | 75 |
| Factor | Score |
|---|---|
| Trend Analysis | 20 |
| Momentum | 50 |
| Volume Confirmation | 50 |
| Support & Resistance | 50 |
| Moving Average Convergence Divergence (MACD) | 40 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Positive Short-Term Momentum
The stock has shown positive returns across multiple short-term periods, with a 1M performance of 7.54% and a 6M performance of 26.36%.
Consistent Dividend Payout
The company has a consistent dividend history with a current dividend yield of 2.9%. The last dividend payment was $0.06 with an ex-dividend date of 2025-05-30.
Bearish Points (7)
Declining Revenue and Net Income (Recent Annual)
The company has experienced a significant decline in revenue from $2.69 billion in 2021 to $1.73 billion in 2024, accompanied by a net loss of -$146.59 million in 2024, indicating potential business challenges.
Bearish Long-Term Moving Average Signals
Most long-term moving averages (e.g., 30-day EMA, 50-day EMA, 100-day EMA, 200-day EMA) are indicating 'Sell' signals, suggesting a prevailing downtrend or resistance.
Calendar
May 2025
30
Ex-Dividend Date
June 2025
11
Next Dividend Date
August 2025
8
Next Earnings Date
H: $
A: $
L: $
Profile
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Seasonals
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 100
Major owner and investor in NuScale Power, providing engineering, procurement, and construction (EPC) services crucial for NuScale's SMR deployment.
Weight: 98
Spin-off from General Electric, its GE-Hitachi Nuclear Energy division is a direct competitor and peer in the development of advanced SMR technologies (BWRX-300).
Weight: 96
Partner in GE-Hitachi Nuclear Energy, making it a direct collaborator in a competing SMR technology development.
Weight: 94
Actively developing its own SMR design in the UK, making it a direct competitor and key player in the global SMR market.